SCHEMBL30150868

SCHEMBL30150868

C[C@H](NC(=O)OC(C)(C)C)C(=O)C=[N+]=[N-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CTSK P43235 8/20 0.39
CYP2D6 P10635 1/20 0.39
KMT2A Q03164 1/20 0.38
CTSS P25774 3/20 0.37
GLS O94925 1/20 0.37
GLA P06280 1/20 0.36
CA12 O43570 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15797149 1.00 CA1 (0.42) CA1CA2CA7CTSKCYP2D6
SCHEMBL30148499 1.00 CA1 (0.42) CA1CA2CA7CTSKCYP2D6
SCHEMBL7121352 0.84 CTSK (0.48) CA1CA2CA7CTSKCYP2D6
SCHEMBL7121346 0.84 CTSK (0.48) CA1CA2CA7CTSKCYP2D6
SCHEMBL31402214 0.84 CTSK (0.48) CA1CA2CA7CTSKCYP2D6
SCHEMBL9754187 0.80 CTSK (0.52) CA1CA2CA7CTSKCYP2D6
SCHEMBL7079069 0.80 CTSK (0.39) CA1CA2CA7CTSKCYP2D6
SCHEMBL6487635 0.80 CTSK (0.39) CA1CA2CA7CTSKCYP2D6
SCHEMBL6991042 0.80 CTSK (0.39) CA1CA2CA7CTSKCYP2D6
SCHEMBL7079066 0.80 CTSK (0.39) CA1CA2CA7CTSKCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024182447-A1 COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K VIVIDION THERAPEUTICS, INC. (US) 2024-09-06 WO disclosed
CN-108341752-B Amine compound for inhibiting SSAO/VAP-1 and application thereof in medicine 广东东阳光药业有限公司 2022-12-23 CN disclosed